Preventive effect of hot compress on phlebitis during cisplatin and Vinorelbine treatment for non-small cell lung cancer
- 19 January 2026
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (2) , 107
Abstract
Background Vinorelbine (VNR) is a key chemotherapeutic agent for treating non-small cell lung cancer (NSCLC). However, peripheral venous administration frequently induces phlebitis in 20–50% of patients. A previous study showed that applying a hot compress during VNR was effective in patients who had already developed symptoms. Therefore, this method was applied to all patients receiving VNR via peripheral venous administration at Hokkaido University Hospital. Herein, we aimed to evaluate the prophylactic efficacy of hot compresses for VNR-induced phlebitis in real-world settings. Methods Patients with NSCLC who received cisplatin (CDDP) + VNR (n = 92) were retrospectively evaluated. Patients were divided into a hot compress group, which included patients who received hot compresses during VNR administration, and a control group that did not receive hot compresses. The primary endpoint was the frequency of phlebitis during the first cycle between the groups. Results Hot compress significantly reduced the frequency of phlebitis during the first cycle (47.3% and 18.9% in the control and hot compress groups, respectively; P = 0.008) and on day 8 of the first cycle (38.2% and 10.8%; P = 0.004), with primary endpoint accomplishment. Furthermore, symptom reduction using hot compresses was confirmed among patients who received VNR on day 8 via a different arm from that administered on day 1 (31.6% vs. 3.0%, P = 0.002). Additionally, the onset of the first occurrence of VNR-induced phlebitis was significantly delayed (P = 0.008). Conclusion Hot compresses significantly reduced the frequency of VNR-induced phlebitis in patients with NSCLC receiving CDDP + VNR.Keywords
This publication has 16 references indexed in Scilit:
- Role of oxidative stress in vinorelbine-induced vascular endothelial cell injuryFree Radical Biology and Medicine, 2010
- Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbitsInternational Journal of Medical Sciences, 2009
- Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicityLung Cancer, 2007
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trialThe Lancet Oncology, 2006
- The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 2005
- Late Phase II Clinical Study of Vinorelbine Monotherapy in Advanced or Recurrent Breast Cancer Previously Treated with Anthracyclines and TaxanesJapanese Journal of Clinical Oncology, 2005
- Vinorelbine and venous irritation: optimal parenteral administrationJournal of Oncology Pharmacy Practice, 2005
- High Body Mass Index Correlates with Increased Risk of Venous Irritation by Vinorelbine InfusionJapanese Journal of Clinical Oncology, 2004
- Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine)1995
- The effect of local heating on blood flow in the finger and the forearm skinCanadian Journal of Physiology and Pharmacology, 1987